Cutaneous mucormycosis infection owing to Rhizomucor variabilis presenting as recurrent lower limb ulceration and cellulitis in a diabetic patient.
Humans
Mucormycosis
/ diagnosis
Cellulitis
/ microbiology
Male
Diabetes Mellitus, Type 2
/ complications
Antifungal Agents
/ therapeutic use
Leg Ulcer
/ microbiology
Dermatomycoses
/ diagnosis
Rhizomucor
/ isolation & purification
Amphotericin B
/ therapeutic use
Recurrence
Middle Aged
Triazoles
/ therapeutic use
Rhizopus
/ isolation & purification
Journal
Dermatology online journal
ISSN: 1087-2108
Titre abrégé: Dermatol Online J
Pays: United States
ID NLM: 9610776
Informations de publication
Date de publication:
15 Apr 2024
15 Apr 2024
Historique:
received:
10
05
2024
accepted:
10
05
2024
medline:
4
7
2024
pubmed:
4
7
2024
entrez:
3
7
2024
Statut:
epublish
Résumé
Primary cutaneous mucormycosis is caused by environmental fungi and may complicate leg ulcers or traumatic wounds even in immunocompetent individuals. This case report highlights recurrent lower limb ulcers and cellulitis in a patient with type two diabetes mellitus, which was unresponsive to conventional antibiotic treatment. Histopathology revealed the diagnosis of cutaneous mucormycosis, and fungal cultures identified Rhizopus variabilis as the causative organism. Initial courses of oral azole antifungals yielded only partial response and he eventually required more aggressive treatment with i.v. amphotericin B and oral posaconazole. Good treatment outcomes for this condition require a high index of clinical suspicion, early histopathological and microbiological diagnosis, targeted systemic antifungal therapy, and surgical debridement if necessary.
Substances chimiques
Antifungal Agents
0
Amphotericin B
7XU7A7DROE
Triazoles
0
posaconazole
6TK1G07BHZ
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM